Morgan Stanley Downgrades Neurocrine Bio. (NBIX) to Equalweight
Tweet Send to a Friend
Morgan Stanley analyst Jeffrey Hung downgraded Neurocrine Bio. (NASDAQ: NBIX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
